SI‑BONE Insider Buying: Jeffrey Dunn Re‑Acquires 20,000 Shares Amid Market Sell‑Offs

Insider Activity at SI‑BONE Inc.: A Detailed Examination

The latest Form 4 filed by the Securities and Exchange Commission on August 3, 2026 reveals that Jeffrey W. Dunn, a senior executive of SI‑BONE Inc., purchased 20 000 shares of the company’s common stock at an average price of $4.68 per share. This transaction follows a period during which Dunn sold roughly 70 000 shares at prices ranging from $13.15 to $21.28. The most recent sale, on June 5, 2026, involved 3 575 shares at $15.25, reducing his holding from 20 114 to 16 057 shares. The August purchase restores his position to 36 057 shares, nearly matching the 36‑k share level he maintained prior to the series of sales.

Contextualizing the Transaction

Dunn’s oscillation between selling and buying aligns with a “trading‑plan” strategy. His August 3 purchase was executed under a 10‑b‑5‑1 plan dated May 7, 2025, allowing him to lock in a purchase price before any material, market‑moving information becomes public. This indicates that the company’s leadership believes the stock is fairly valued and that recent earnings—$18.44 closing price, 15 % revenue growth, and a narrowing loss—justify a long‑term stake. For investors, the move suggests that insiders remain willing to accumulate shares, a potential positive signal. Nevertheless, the broader insider sell‑side activity—particularly the substantial blocks sold by Pisecky, Maheshwari, and Francis in July—tempers enthusiasm, underscoring the need for caution until the company’s guidance and cash‑flow profile are further clarified.

Historical Trading Patterns

Dunn has historically been a frequent seller. He began the year with a 20 000‑share sale at $21.28 on January 8, 2026, and subsequently sold 337 shares in early May and another 337 in February at prices above $16. The most notable block sale was 18 759 shares on December 8, 2025, at $19.33, all of which occurred at or above the 12‑month high of $21.89. These sales reflect an inclination to capitalize on strong market prices. Conversely, Dunn has also made several purchases—most recently 1 241 shares at $4.32 in December 2025—indicating comfort with buying back into the company when the price dips below the 52‑week low of $11.48. This pattern portrays him as a “price‑reactive” insider: selling during peaks and buying during troughs, aiming to average down over time.

Implications for SI‑BONE’s Future

SI‑BONE’s recent results and guidance revisions have already pushed the share price down 2.17 % for the week, yet the company remains within its 52‑week high/low range. The earnings report highlighted a 15 % revenue lift, but the P/E ratio remains negative at –46.1, reflecting ongoing net losses. Insider buying such as Dunn’s suggests confidence that the company will return to profitability as its minimally invasive solutions gain market share. For investors, the best takeaway is to monitor the next earnings call and watch for any further insider trades—particularly if a larger block sale is announced, which could signal a shift in sentiment.

Bottom Line

Jeffrey W. Dunn’s recent purchase exemplifies disciplined, rule‑based insider trading that balances risk and reward. While insider selling has been aggressive, the consistent accumulation points to a long‑term belief in SI‑BONE’s product pipeline and market positioning. Investors should weigh this insider sentiment against the company’s negative earnings and the broader sell‑side activity, remaining vigilant for any sudden changes in insider ownership that could precede a market move.